Correction to: Efficacy of Radiofrequency Ablation in Patients with Metastatic Liver Tumors from Breast Carcinoma

Authors

  • Gahsem Janbabai Associate Professor, Department of Oncology, Gastrointestinal Cancer Research Center, Mazandaran University of Medical Sciences, Sari, Iran
  • Maryam Tayebi MSc in Medical Imaging, Department of Radiology, Sari Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran
  • Mohammad Khademloo Associate Professor, Department of Community Medicine, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
  • Seyed Ghader Aghili Radiologist, Department of Radiology, Sari Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran
  • Yaghob Sakhaeei Assisstant Professor, Department of Radiology, Faculty of Medicine, Islamic Azad University, Sari Branch, Mazandaran, Sari, Iran
  • Zahra Mardanshahi Assistant Professor, Department of Radiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
Abstract:

In the article published in Volume 27, issue 158, 2017, the Results section in English Abstract have been published incorrectly. The correct Results is given below: &nbsp; Results: The most frequent sizes of mass were 2-4 cm (n=33, 54%) and 4-5 cm (n=23, 38%). Among the patients, 35 (67.3%) had one tumor before, in 11.5% renew tumor happened, and 65.4% had one tumor after treatment. Liver tumors were controlled in 76.9% in case group which was statistically higher than that in control group (P< 0.0001). &nbsp;

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Radiofrequency Ablation of Primary or Metastatic Liver Tumors

©2017 Blue Cross and Blue Shield of Louisiana An independent licensee of the Blue Cross and Blue Shield Association No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, or otherwise, without permission from Blue Cross and Blue Shield of Louisiana. Page 1 of 20 Applies to all products admin...

full text

Radiofrequency ablation of primary and metastatic liver tumors.

Worldwide, hepatocellular carcinoma (HCC) is one of the most common and deadly solid cancers. At least one million new patients are diagnosed annually with this cancer. Incidence in non-Western countries is related to infections of hepatitis B virus and dietary ingestion of aflatoxins, whereas in Western countries alcohol-related cirrhosis and chronic hepatitis C virus infection are leading cau...

full text

Therapeutic efficacy comparison of radiofrequency ablation in hepatocellular carcinoma and metastatic liver cancer

The aim of this study was to evaluate the effect of radiofrequency ablation (RFA) on malignant hepatic tumors and compare its therapeutic efficacy in hepatocellular carcinoma (HCC) and metastatic liver cancer (MLC). A total of 56 patients with malignant hepatic tumors (34 patients with HCC and 22 patients with MLC) underwent RFA treatment. Two weeks following the RFA treatment, contrast-enhance...

full text

Virtual Radiofrequency Ablation of Liver Tumors

In the last few years, radiofrequency ablation has become one of the most promising techniques to treat liver tumors. But radiologists have to face the difficulty of planning their treatment while only relying on 2D slices. We present here a realistic radiofrequency ablation simulation tool, coupled with a 3D reconstruction and visualization project. They help radiologists to have a better visu...

full text

Radiofrequency Ablation of Miscellaneous Solid Tumors Excluding Liver Tumors - 121616

In radiofrequency ablation (RFA), a probe is inserted into the center of a tumor and the noninsulated electrodes, which are shaped like prongs, are projected into the tumor; a heat is then generated locally by a high-frequency, alternating current that flows from the electrodes. The local heat treats the tissue adjacent to the probe, resulting in a 3 cm to 5.5 cm sphere of dead tissue. The cell...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 28  issue 162

pages  206- 207

publication date 2018-07

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023